AGOMEDIUM SIGNALFINANCIAL10-K

AGO delivered strong financial performance with meaningfully higher revenue and net income, while updating risk disclosures to include cybersecurity and AI threats alongside geopolitical concerns.

The company demonstrated solid operational execution with both top-line and bottom-line growth accelerating meaningfully year-over-year. The updated risk factor language reflects management's increased focus on emerging technological threats and evolving geopolitical risks, suggesting a more comprehensive risk assessment framework that could benefit long-term strategic planning.

Comparing 2026-02-27 vs 2025-02-28View on EDGAR →
FINANCIAL ANALYSIS

AGO showed robust financial performance with revenue growing notably to $1.1 billion while net income expanded substantially to $503 million, indicating strong operational leverage and improved profitability margins. The synchronized growth in both revenue and earnings suggests healthy underlying business momentum. The financial results demonstrate the company's ability to generate meaningful returns while navigating a complex risk environment.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+33.8%
$376.0M→$503.0M

Net income grew 33.8% — bottom-line growth signals improving overall business health.

Revenue
P&L
+27.3%
$872.0M→$1.1B

Revenue growing 27.3% — solid top-line momentum, watch margins for quality of growth.

LANGUAGE CHANGES
NEW — 2026-02-27
PRIOR — 2025-02-28
ADDED
As of February 25, 2026, 44,948,769 Common Shares, par value $0.01 per share, were outstanding (including 22,002 unvested restricted shares).
Securities and Exchange Commission (SEC); (xxxi) other risks and uncertainties that have not been identified at this time; and (xxxii) management s response to these factors.
Assured Guaranty undertakes no obligation to update or review 3 any forward looking statement, whether as a result of new information, future developments or otherwise, except as required by law.
Business 6 Overview 6 Insurance 7 Insurance Business 7 Exposure Limits, Underwriting Process, and Credit Policy 9 Importance of Financial Strength Ratings 11 Market Demand and Competition 12 Financial Guaranty Insurance Acquisitions 14 Insurance Subsidiaries 14 Support of the European Insurance Subsidiaries 15 Asset Management 16 Asset Management Strategies 17 Market Demand and Competition 17 Investments 18 Risk Management 19 Regulation 23 Human Capital Management 33 Tax Matters 34 Available Information 42 Item 1A.
Risk Factors 43 Risks Related to Economic, Market and Political Conditions and Natural Phenomena 45 Risks Related to Estimates, Assumptions and Valuations 47 Strategic Risks 49 Operational Risks 53 Risks Related to Taxation 57 Risks Related to Applicable Law, Litigation and GAAP 61 Risks Related to AGL s Common Shares 64 Item 1B.
+7 more — sign up free →
REMOVED
As of February 26, 2025, 50,103,140 Common Shares, par value $0.01 per share, were outstanding (including 21,413 unvested restricted shares).
China strategic competition; (iii) cybersecurity risk and the impacts of artificial intelligence, machine learning and other technological advances, including potentially increasing the risks of malicious cyber attacks, dissemination of misinformation, and disruption of markets, including the markets in which the Company participates; (iv) the possibility of a U.S.
government shutdown, payment defaults on the debt of the U.S.
government or instruments issued, insured or guaranteed by related institutions, agencies or instrumentalities, and downgrades to their credit ratings; (v) developments in the world s financial and capital markets, including stresses in the financial condition of banking institutions in the U.S.
Securities and Exchange Commission (SEC); (xxviii) other risks and uncertainties that have not been identified at this time; and (xxix) management s response to these factors.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →